Literature DB >> 2079377

[Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].

F Kees1, K G Naber.   

Abstract

The pharmacokinetic parameters of cefixime were determined in healthy volunteers following oral administration of 200 mg cefixime as tablet, syrup and dry suspension, respectively. All three galenic formulations showed reliable absorption. Mean peak plasma concentrations amounted to 2.4-3.4 mg/l and were reached after 3.3-3.5 h. Mean terminal half-lives were 2.9-3.1 h. The mean areas under the plasma concentration-time curves ranged between 18 and 26 mg/l.h; 18-24% of the dose administered were recovered unchanged in the urine. The best bioavailability was obtained with the dry suspension followed by the tablet and the syrup. With respect to the ester pro-drug cephalosporins, cefuroxime axetil, cefetamet pivoxyl and cefotiam hexetil, cefixime exhibits higher plasma half-life and area under the curve as well as, comparable absolute bioavailability but consistently lower urinary recovery which indicates higher non-renal clearance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079377     DOI: 10.1007/BF01644636

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  The pharmacokinetics of cefixime in patients with renal insufficiency undergoing hemofiltration.

Authors:  S König; R Marre; E Schulz; K Sack
Journal:  J Chemother       Date:  1989-07       Impact factor: 1.714

2.  Relative bioavailability of three cefixime formulations.

Authors:  F Kees; K G Naber; G Sigl; W Ungethüm; H Grobecker
Journal:  Arzneimittelforschung       Date:  1990-03

3.  Characterization of the transport system for beta-lactam antibiotics and dipeptides in rat renal brush-border membrane vesicles by photoaffinity labeling.

Authors:  W Kramer; I Leipe; E Petzoldt; F Girbig
Journal:  Biochim Biophys Acta       Date:  1988-03-22

Review 4.  Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.

Authors:  K Stoeckel; Y K Tam; J Kneer
Journal:  Curr Med Res Opin       Date:  1989       Impact factor: 2.580

5.  [Bioavailability of penicillin V in aqueous dosage forms].

Authors:  W Lintz; I Hirsch; G Osterloh; E Schmidt-Böthelt; H Sous
Journal:  Arzneimittelforschung       Date:  1984

6.  The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

Authors:  P E Williams; S M Harding
Journal:  J Antimicrob Chemother       Date:  1984-02       Impact factor: 5.790

7.  Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.

Authors:  D R Guay; R C Meatherall; G K Harding; G R Brown
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

8.  Absolute bioavailability of cefixime in man.

Authors:  R D Faulkner; P Fernandez; G Lawrence; L L Sia; A J Falkowski; A I Weiss; A Yacobi; B M Silber
Journal:  J Clin Pharmacol       Date:  1988-08       Impact factor: 3.126

Review 9.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

10.  Pharmacokinetic profile of cefixime in man.

Authors:  R D Faulkner; A Yacobi; J S Barone; S A Kaplan; B M Silber
Journal:  Pediatr Infect Dis J       Date:  1987-10       Impact factor: 2.129

View more
  1 in total

1.  Pharmacokinetics of loracarbef and interaction with acetylcysteine.

Authors:  S Roller; H Lode; I Stelzer; K M Deppermann; M Boeckh; P Koeppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.